# Eversept Partners, LP 13F holdings Q2 2026: $1.9 billion

Eversept Partners, LP reported $1.9 billion in 13F securities across 120 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was United Therapeutics Corp Del at $156 million, 8.1% of the reported value. Since Q1 2026 it opened 32 new positions and exited 32.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $1,927,640,043
- Positions: 120
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1697013
- Form 13F file number: 028-18369
- Business address: 444 Madison Avenue 22nd Floor, New York, NY 10022
- SEC filing: [0001697013-26-000005](https://www.sec.gov/Archives/edgar/data/1697013/000169701326000005/0001697013-26-000005-index.htm)

## Top 25 holdings by value

The largest of 120 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 287,668 | $155.9 million | +23,397 |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 913,880 | $121.8 million | -20,543 |
| [Encompass Health Corp](https://specstream.ai/data/institutional-holders/encompass-health-corp-29261a100) | COM | 1,026,919 | $103.8 million | +832,815 |
| [Ensign Group Inc](https://specstream.ai/data/institutional-holders/ensign-group-inc-29358p101) | COM | 602,079 | $96.5 million | +587,318 |
| [Vera Therapeutics Inc](https://specstream.ai/data/institutional-holders/vera-therapeutics-inc-92337r101) | CL A | 2,212,770 | $94.9 million | +39,484 |
| Invesco QQQ TR | UNIT SER 1 (put) | 98,600 | $72.6 million | -140,100 |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 1,785,941 | $66.5 million | -2,075 |
| [Syndax Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/syndax-pharmaceuticals-inc-87164f105) | COM | 2,798,210 | $61.2 million | -87,412 |
| [Brookdale Sr Living Inc](https://specstream.ai/data/institutional-holders/brookdale-sr-living-inc-112463104) | COM | 3,396,470 | $54.6 million | -172,085 |
| [Ionis Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ionis-pharmaceuticals-inc-462222100) | COM | 664,684 | $52.7 million | +32,584 |
| [Natera Inc](https://specstream.ai/data/institutional-holders/natera-inc-632307104) | COM | 175,807 | $47.7 million | -208,906 |
| [Travere Therapeutics Inc](https://specstream.ai/data/institutional-holders/travere-therapeutics-inc-89422g107) | COM | 798,973 | $45.4 million | +256,363 |
| [Caretrust REIT Inc](https://specstream.ai/data/institutional-holders/caretrust-reit-inc-14174t107) | COM | 1,072,015 | $43.3 million | New |
| [Hca Healthcare Inc](https://specstream.ai/data/institutional-holders/hca-healthcare-inc-40412c101) | COM | 98,252 | $38.3 million | +19,023 |
| [Vaxcyte Inc](https://specstream.ai/data/institutional-holders/vaxcyte-inc-92243g108) | COM | 629,952 | $36.6 million | -294,241 |
| [Liquidia Corporation](https://specstream.ai/data/institutional-holders/liquidia-corporation-53635d202) | COM NEW | 428,652 | $34.2 million | -248,740 |
| [Community Health Sys Inc New](https://specstream.ai/data/institutional-holders/community-health-sys-inc-new-203668108) | COM | 7,864,575 | $26.3 million | -812,706 |
| [GSK PLC](https://specstream.ai/data/institutional-holders/gsk-plc-37733w204) | SPONSORED ADR | 481,833 | $25.3 million | -1,303,342 |
| [Chemed Corp New](https://specstream.ai/data/institutional-holders/chemed-corp-new-16359r103) | COM | 52,523 | $24.5 million | +21,466 |
| [Eli Lilly & Co](https://specstream.ai/data/institutional-holders/eli-lilly-co-532457108) | COM | 20,116 | $24.1 million | +1,116 |
| [Geron Corp](https://specstream.ai/data/institutional-holders/geron-corp-374163103) | COM | 18,717,422 | $24 million | -117,461 |
| [Viking Therapeutics Inc](https://specstream.ai/data/institutional-holders/viking-therapeutics-inc-92686j106) | COM | 602,922 | $23.5 million | +363,812 |
| [Omega Healthcare Invs Inc](https://specstream.ai/data/institutional-holders/omega-healthcare-invs-inc-681936100) | COM | 483,547 | $23.1 million | -102,133 |
| [Insulet Corp](https://specstream.ai/data/institutional-holders/insulet-corp-45784p101) | COM | 148,816 | $22.7 million | +5,270 |
| [Tenet Healthcare Corp](https://specstream.ai/data/institutional-holders/tenet-healthcare-corp-88033g407) | COM NEW | 114,199 | $21.4 million | +84,687 |

## New positions in Q2 2026

32 positions not in the filing for the quarter ended March 31, 2026. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Caretrust REIT Inc](https://specstream.ai/data/institutional-holders/caretrust-reit-inc-14174t107) | COM | 1,072,015 | $43.3 million |
| [Unitedhealth Group Inc](https://specstream.ai/data/institutional-holders/unitedhealth-group-inc-91324p102) | COM | 51,145 | $21.3 million |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 490,235 | $19 million |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 149,209 | $15.9 million |
| [Amn Healthcare SVCS Inc](https://specstream.ai/data/institutional-holders/amn-healthcare-svcs-inc-001744101) | COM | 428,531 | $13.9 million |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 127,931 | $13.4 million |
| [Humana Inc](https://specstream.ai/data/institutional-holders/humana-inc-444859102) | COM | 31,171 | $12.4 million |
| [Corvus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/corvus-pharmaceuticals-inc-221015100) | COM | 747,994 | $11.2 million |
| [Ascendis Pharma A/S](https://specstream.ai/data/institutional-holders/ascendis-pharma-a-s-k08588103) | ORD SHS | 41,621 | $11.1 million |
| [Mineralys Therapeutics Inc](https://specstream.ai/data/institutional-holders/mineralys-therapeutics-inc-603170101) | COM | 309,689 | $8.4 million |
| [Novo-Nordisk a S](https://specstream.ai/data/institutional-holders/novo-nordisk-a-s-670100205) | ADR | 169,227 | $8.1 million |
| [Biohaven LTD](https://specstream.ai/data/institutional-holders/biohaven-ltd-g1110e107) | COM | 515,804 | $7.7 million |
| [Protagonist Therapeutics Inc](https://specstream.ai/data/institutional-holders/protagonist-therapeutics-inc-74366e102) | COM | 58,504 | $7.2 million |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 136,631 | $6.9 million |
| [Beam Therapeutics Inc](https://specstream.ai/data/institutional-holders/beam-therapeutics-inc-07373v105) | COM | 166,289 | $5.7 million |
| [National Health Invs Inc](https://specstream.ai/data/institutional-holders/national-health-invs-inc-63633d104) | COM | 70,673 | $5.4 million |
| [Pacs Group Inc](https://specstream.ai/data/institutional-holders/pacs-group-inc-69380q107) | COM SHS | 117,441 | $5 million |
| [National Healthcare Corp](https://specstream.ai/data/institutional-holders/national-healthcare-corp-635906100) | COM | 22,116 | $4.7 million |
| [Eyepoint Inc](https://specstream.ai/data/institutional-holders/eyepoint-inc-30233g209) | COM NEW | 297,735 | $4.3 million |
| [Tarsus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/tarsus-pharmaceuticals-inc-87650l103) | COM | 55,710 | $3.5 million |
| [Vor Biopharma Inc](https://specstream.ai/data/institutional-holders/vor-biopharma-inc-929033207) | COM NEW | 149,681 | $2.8 million |
| [Design Therapeutics Inc](https://specstream.ai/data/institutional-holders/design-therapeutics-inc-25056l103) | COM | 190,000 | $2.7 million |
| [Spruce Biosciences Inc](https://specstream.ai/data/institutional-holders/spruce-biosciences-inc-85209e208) | COM NEW | 40,000 | $2.2 million |
| [Proqr Thrapeutics N V](https://specstream.ai/data/institutional-holders/proqr-thrapeutics-n-v-n71542109) | SHS EURO | 1,022,265 | $1.9 million |
| [Revolution Medicines Inc](https://specstream.ai/data/institutional-holders/revolution-medicines-inc-76155x100) | COM | 6,943 | $1.3 million |

## Positions exited in Q2 2026

32 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then. The 25 largest are shown.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| State STR SPDR S&P 500 ETF T | TR UNIT (put) | 107,000 | $69.6 million |
| Vertex Pharmaceuticals Inc | COM (call) | 90,000 | $40.2 million |
| Ishares TR | 20 YR TR BD ETF (put) | 428,800 | $37.2 million |
| [Healthpeak Properties Inc](https://specstream.ai/data/institutional-holders/healthpeak-properties-inc-42250p103) | COM | 1,981,070 | $32.5 million |
| [Avantor Inc](https://specstream.ai/data/institutional-holders/avantor-inc-05352a100) | COM | 2,974,287 | $23.3 million |
| [Qiagen NV](https://specstream.ai/data/institutional-holders/qiagen-nv-n72482156) | ORD SHARES | 545,330 | $21.8 million |
| Ishares TR | IBOXX HI YD ETF (put) | 180,000 | $14.3 million |
| Unitedhealth Group Inc | COM (call) | 40,000 | $10.8 million |
| Ishares TR | RUSSELL 2000 ETF (put) | 40,000 | $9.9 million |
| Select Sector SPDR TR | ST STR TECHN ETF (put) | 70,000 | $9.3 million |
| [Icon PLC](https://specstream.ai/data/institutional-holders/icon-plc-g4705a100) | SHS | 68,688 | $7.6 million |
| [Agios Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/agios-pharmaceuticals-inc-00847x104) | COM | 200,000 | $6.8 million |
| [Madrigal Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/madrigal-pharmaceuticals-inc-558868105) | COM | 10,000 | $5.2 million |
| Praxis Precision Medicines I | COM NEW (put) | 14,800 | $4.8 million |
| [Esperion Therapeutics Inc Ne](https://specstream.ai/data/institutional-holders/esperion-therapeutics-inc-ne-29664w105) | COM | 1,735,963 | $4.8 million |
| [Healthequity Inc](https://specstream.ai/data/institutional-holders/healthequity-inc-42226a107) | COM | 51,614 | $4.3 million |
| Day One Biopharmaceuticals I | COM | 183,902 | $3.9 million |
| [Centene Corp Del](https://specstream.ai/data/institutional-holders/centene-corp-del-15135b101) | COM | 111,652 | $3.7 million |
| Engene Holdings Inc | COM | 510,543 | $3.5 million |
| Enhabit Inc | COM | 227,451 | $3.2 million |
| Select Sector SPDR TR | STATE STREET ENE (call) | 50,000 | $3.1 million |
| [Sutro Biopharma Inc](https://specstream.ai/data/institutional-holders/sutro-biopharma-inc-869367201) | COM SHS | 73,161 | $1.8 million |
| [Novocure LTD](https://specstream.ai/data/institutional-holders/novocure-ltd-g6674u108) | ORD SHS | 134,917 | $1.5 million |
| [Bioventus Inc](https://specstream.ai/data/institutional-holders/bioventus-inc-09075a108) | COM CL A | 159,110 | $1.5 million |
| [Immunocore Hldgs PLC](https://specstream.ai/data/institutional-holders/immunocore-hldgs-plc-45258d105) | ADS | 39,238 | $1.2 million |

## Also on SpecStream

- [Eversept Partners, LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1697013/000169701326000005/0001697013-26-000005-index.htm)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Recycling centers in New York, New York](https://specstream.ai/data/businesses/recycling-centers/new-york-new-york-united-states)
- [Public schools in New York, New York](https://specstream.ai/data/businesses/public-schools/new-york-new-york-united-states)
- [Private investigators in New York, New York](https://specstream.ai/data/businesses/private-investigators/new-york-new-york-united-states)
- [Pizza restaurants in New York, New York](https://specstream.ai/data/businesses/pizza-restaurants/new-york-new-york-united-states)
- [Pediatric clinics in New York, New York](https://specstream.ai/data/businesses/pediatric-clinics/new-york-new-york-united-states)
- [Optometrists in New York, New York](https://specstream.ai/data/businesses/optometrists/new-york-new-york-united-states)
